3 years ago
ARQT
AnalystsUy EarUy Ear's Stock Forecasts
AnalystsUy Ear
Analyst Ranking
Top 15%
#813 out of 5513 analysts
Average Return
+17.9%
Win Rate
48%29 out of 60
Risk vs Reward
Poor
Good
Uy Ear's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mbx Biosciences IncMBX | +491.63% | $11.95 | $70.70 | 2025-08-05 - 2026-08-04 | Buy |
Arcutis Biotherapeutics IncARQT | +306.12% | $3.43 | $13.93 | 2024-01-02 - 2024-12-31 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +272.38% | $3.91 | $14.56 | 2024-01-03 - 2025-01-02 | Strong Buy |
Mbx Biosciences IncMBX | +217.86% | $20.10 | $63.89 | 2025-09-24 - 2026-09-17 | Buy |
Uniqure NvQURE | +151.08% | $17.56 | $44.09 | 2026-03-11 - 2026-09-17 | Buy |
Uy Ear Analyst Color
Get additional color on Uy Ear's coverage of popular stocks
Uy Ear's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Mbx Biosciences IncMBX | 3 | Buy | $91.00 | +42.43% | Maintains | 2 months ago |
Alkermes PLCALKS | 7 | Buy | $65.00 | +39.16% | Maintains | 3 months ago |
Uniqure NvQURE | 9 | Buy | $68.00 | +54.23% | Maintains | 3 months ago |
Sol Gel Technologies LtdSLGL | 1 | Buy | $285.00 | +341.59% | Initiates Coverage On | 3 months ago |
Relmada Therapeutics IncRLMD | 3 | Buy | $19.00 | +352.38% | Maintains | 6 months ago |
Sarepta Therapeutics IncSRPT | 9 | Buy | $31.00 | +49.98% | Maintains | 6 months ago |
Arcutis Biotherapeutics IncARQT | 15 | Buy | $35.00 | +32.28% | Maintains | 7 months ago |
Acadia Pharmaceuticals IncACAD | 16 | Buy | $35.00 | +27.50% | Upgrades | 7 months ago |
Neurocrine Biosciences IncNBIX | 10 | Hold | $175.00 | +15.26% | Maintains | 9 months ago |
Evolus IncEOLS | 4 | Buy | $19.00 | +137.20% | Maintains | 10 months ago |
Tectonic Therapeutic IncTECX | 6 | Buy | $85.00 | N/A | Maintains | a year ago |
Sage Therapeutics IncSAGE | 2 | Hold | $16.00 | N/A | Maintains | 2 years ago |
Cartesian Therapeutics IncRNAC | 3 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 2 years ago |
Revance Therapeutics IncRVNC | 1 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Johnson & JohnsonJNJ | 1 | Strong Buy | $40.00 | N/A | Maintains | 3 years ago |
Satsuma Pharmaceuticals IncSTSA | 1 | Hold | $2.00 | N/A | Reiterates | 3 years ago |
Cabaletta Bio IncCABA | 1 | Strong Buy | $10.00 | N/A | Reiterates | 4 years ago |
Ocugen IncOCGN | 2 | Strong Buy | $3.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.